As PGE2 is a major metabolite of COX-2 and has been implicated in COX-2-mediated adverse effects including the invasion and metastasis of cancer cells; we determined the levels of PGE2 in the honokiol-treated cells using PGE2 immunoassay kit. Here, PTGS2 is linked to cancer.